Zolopa A - Search Results

1

Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection.

Grant PM, Komarow L, Andersen J, Sereti I, Pahwa S, Lederman MM, Eron J, Sanne I, Powderly W, Hogg E, Suckow C, Zolopa A. Grant PM, et al. Among authors: zolopa a. PLoS One. 2010 Jul 1;5(7):e11416. doi: 10.1371/journal.pone.0011416. PLoS One. 2010. PMID: 20617176 Free PMC article. Clinical Trial.

2

Initiation of antiretroviral therapy in the hospitalized patient with an acute AIDS-related opportunistic infection and other conditions: no time to lose.

Grant P, Zolopa A. Grant P, et al. Among authors: zolopa a. Curr HIV/AIDS Rep. 2009 May;6(2):63-7. doi: 10.1007/s11904-009-0010-3. Curr HIV/AIDS Rep. 2009. PMID: 19358776 Review.

3

Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial.

Zolopa A, Andersen J, Powderly W, Sanchez A, Sanne I, Suckow C, Hogg E, Komarow L. Zolopa A, et al. PLoS One. 2009;4(5):e5575. doi: 10.1371/journal.pone.0005575. Epub 2009 May 18. PLoS One. 2009. PMID: 19440326 Free PMC article. Clinical Trial.

4

The use of resistance testing in the management of HIV-1-infected patients.

Grant PM, Zolopa AR. Grant PM, et al. Curr Opin HIV AIDS. 2009 Nov;4(6):474-80. doi: 10.1097/COH.0b013e328331c14f. Curr Opin HIV AIDS. 2009. PMID: 20048713 Review.

5

Optimal antiretroviral therapy: HIV-1 treatment strategies to avoid and overcome drug resistance.

Grant PM, Zolopa AR. Grant PM, et al. Curr Opin Investig Drugs. 2010 Aug;11(8):901-10. Curr Opin Investig Drugs. 2010. PMID: 20721832 Review.

6

When to start ART in the setting of acute AIDS-related opportunistic infections: the time is now!

Grant PM, Zolopa AR. Grant PM, et al. Curr HIV/AIDS Rep. 2012 Sep;9(3):251-8. doi: 10.1007/s11904-012-0126-8. Curr HIV/AIDS Rep. 2012. PMID: 22733609 Review.

7

Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome during ACTG A5164.

Grant PM, Komarow L, Lederman MM, Pahwa S, Zolopa AR, Andersen J, Asmuth DM, Devaraj S, Pollard RB, Richterman A, Kanthikeel S, Sereti I. Grant PM, et al. Among authors: zolopa ar. J Infect Dis. 2012 Dec 1;206(11):1715-23. doi: 10.1093/infdis/jis604. Epub 2012 Sep 21. J Infect Dis. 2012. PMID: 23002445 Free PMC article.

8

Integrase inhibitors: a clinical review of raltegravir and elvitegravir.

Grant P, Zolopa A. Grant P, et al. Among authors: zolopa a. J HIV Ther. 2008 Jun;13(2):36-9. J HIV Ther. 2008. PMID: 18953272 Review. No abstract available.

9

Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.

Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, Qasba SS, Luetkemeyer AF, Hogg E, Rooney JF, Wu X, Hosseinipour MC, Lalloo U, Veloso VG, Some FF, Kumarasamy N, Padayatchi N, Santos BR, Reid S, Hakim J, Mohapi L, Mugyenyi P, Sanchez J, Lama JR, Pape JW, Sanchez A, Asmelash A, Moko E, Sawe F, Andersen J, Sanne I; AIDS Clinical Trials Group Study A5221. Havlir DV, et al. N Engl J Med. 2011 Oct 20;365(16):1482-91. doi: 10.1056/NEJMoa1013607. N Engl J Med. 2011. PMID: 22010914 Free PMC article. Clinical Trial.

10

Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation.

Grant PM, Kitch D, McComsey GA, Dube MP, Haubrich R, Huang J, Riddler S, Tebas P, Zolopa AR, Collier AC, Brown TT. Grant PM, et al. Among authors: zolopa ar. Clin Infect Dis. 2013 Nov;57(10):1483-8. doi: 10.1093/cid/cit538. Epub 2013 Aug 13. Clin Infect Dis. 2013. PMID: 23943825 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

118 results

Search Page